Creative Commons source reading · Brain aging and cognitive reserve
Trimethylamine-N-oxide promotes brain aging and cognitive impairment in mice.
Dang Li; Yilang Ke; Rui Zhan; Changjie Liu; Mingming Zhao; Aiping Zeng; Xiaoyun Shi; Liang Ji; Si Cheng; Bing Pan; Lemin Zheng; Huashan Hong
Originally published in Aging cell · 2018-05-10
From the article
Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.
Abstract
Gut microbiota can influence the aging process and may modulate aging-related changes in cognitive function. Trimethylamine-N-oxide (TMAO), a metabolite of intestinal flora, has been shown to be closely associated with cardiovascular disease and other diseases. However, the relationship between TMAO and aging, especially brain aging, has not been fully elucidated. To explore the relationship between TMAO and brain aging, we analysed the plasma levels of TMAO in both humans and mice and administered exogenous TMAO to 24-week-old senescence-accelerated prone mouse strain 8 (SAMP8) and age-matched senescence-accelerated mouse resistant 1 (SAMR1) mice for 16 weeks. We found that the plasma levels of TMAO increased in both the elderly and the aged mice. Compared with SAMR1-control mice, SAMP8-control mice exhibited a brain aging phenotype characterized by more senescent cells in the hippocampal CA3 region and cognitive dysfunction. Surprisingly, TMAO treatment increased the number of senescent cells, which were primarily neurons, and enhanced the mitochondrial impairments and superoxide production.
DISCUSSION
Previous studies have emphasized the influence of gut microbiota in the development of many diseases (Adnan et al., 2017; Tang & Hazen, 2014). TMAO, a metabolite of intestinal flora, was shown to be closely associated with age‐related diseases. The level of plasma TMAO can be influenced by several factors (Romano, Vivas, Amadornoguez & Rey, 2015), including gut microbiota, diet, liver FMO enzymes and kidney function. Previous studies have shown that aging can alter the structure and function of intestinal flora (O'Toole & Jeffery, 2015), especially in elderly people (>65 years of age) (Claesson et al., 2012).
Editorial reading guide
- Was the evidence cross-sectional, longitudinal or experimental?
- How did the authors account for age, disease stage and differences among participants?
